Should I Buy BON? BON 2026 Analysis

Should You Buy Bon Natural Life Ltd (BON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.630

1 Day change

52 Week Range

73.750

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: there is no Intellectia buy signal, price is sitting near a key pivot, and near-term pattern odds skew slightly negative.
Best stance is to HOLD/WAIT for a clearer breakout above ~~1.725 (R1) or a pullback closer to support (~~1.641 / 1.615) with improving momentum.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Pre-market price ~1.67 is just below the pivot (1.683), suggesting indecision at a key decision level.
MACD histogram is slightly above zero and expanding (mild bullish momentum building), but not strong.
RSI(6) = 46.07 (neutral), indicating no oversold bounce setup and no strong bullish pressure.
Moving averages are converging (range-bound / transition phase rather than a clean trend).
Levels to watch:
- Resistance: 1.725 (R1), then 1.751 (R2)
- Support: 1.641 (S1), then 1.615 (S2)
Pattern-based forward odds: ~60% chance of -0.2% next day and -0.52% next week, with a more constructive +2.61% bias over the next month (not ideal for someone unwilling to wait).

Positive Catalysts

- Mild momentum improvement (MACD positive and expanding).
- Model-based 1-month bias is positive (+2.61%), implying potential for a delayed upside move.
- No notable hedge fund or insider selling pressure indicated (both neutral).

Neutral/Negative Catalysts

- No news in the last week, so no clear event-driven catalyst to spark immediate upside.
- No Intellectia AI Stock Picker or SwingMax buy signal, reducing conviction for an immediate entry.
- Near-term statistical edge is slightly negative (next day/week drift).
- Trading trends: Hedge funds neutral (no accumulation signal); insiders neutral (no supportive buying signal).
- Congress trading: no recent congress trading data available.

Financial Performance

Financial snapshot unavailable (data error: list index out of range), so latest quarter/season growth and profitability trends cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target updates were provided, suggesting limited/unclear Wall Street coverage in this dataset.
Wall Street pros/cons view cannot be reliably summarized from the supplied information due to missing analyst data.

Analyst Rating

Wall Street analysts forecast BON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BON is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.630

Low

Averages

High